"Now researchers at the Karolinska Institutet and KTH's MedTechLabs want to solve the mystery of the disease with mathematical calculations and machine learning algorithms."

Clara Hellner, director of research and innovation for Region Stockholm and chairman of Medtechlabs, talks about her career and the challenges in her current roles.

"At the beginning of 2020, Peder Olofsson started a new interdisciplinary collaboration with KTH within the research center Medtechlabs where doctors, immunologists, engineers and mathematicians collaborate. "We analyze nerve signals during inflammation with the aim of laying the foundation for automatically controlling anti-inflammatory treatment," he says. Trials on patients with chronic inflammation are already underway internationally. "Clinical studies of rheumatism and inflammatory bowel disease show encouraging preliminary results. But larger and better designed studies and more precise methods of nerve stimulation are needed to generate more confident observations."